Brad Salisbury, | |
4309 Buffalo Rd, Erie, PA 16510-2113 | |
(814) 897-7871 | |
Not Available |
Full Name | Brad Salisbury |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 4309 Buffalo Rd, Erie, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013289909 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | RP042029L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Brad Salisbury, 4309 Buffalo Rd, Erie, PA 16510-2113 Ph: (814) 897-7871 | Brad Salisbury, 4309 Buffalo Rd, Erie, PA 16510-2113 Ph: (814) 897-7871 |
News Archive
"It's in their genes" is a common refrain from scientists when asked about factors that allow centenarians to reach age 100 and beyond. Up until now, research has focused on genetic variations that offer a physiological advantage such as high levels of HDL cholesterol. But researchers at Albert Einstein College of Medicine and Ferkauf Graduate School of Psychology of Yeshiva University have found that personality traits like being outgoing, optimistic, easygoing, and enjoying laughter as well as staying engaged in activities may also be part of the longevity genes mix.
Ion Torrent today announced that it is extending its Ion PGM Sequencer Grant Program to Europe, and will award two sequencers to scientists there in the second half of 2010. This spring Ion Torrent received hundreds of grant proposals from scientists in North America, and in April two winners were each awarded an Ion PGM sequencer.
Postmenopausal women who have a history of gum disease also have a higher risk of cancer, according to a new study of more than 65,000 women.
An independent panel convened last week by the National Institutes of Health found that many women move through the menopausal transition with few disabling symptoms, and that it is important that menopause not be viewed as a disease.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, reported dosing of the first patient in a Phase 3 study for ARX-01, the Sufentanil NanoTab PCA System, its novel sublingual patient-controlled analgesia system.
› Verified 9 days ago
Kim C Dirienzo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 925 W Erie Plz, Erie, PA 16505 Phone: 814-454-7800 Fax: 814-454-0600 | |
Kylee Gross, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5515 Peach St, Erie, PA 16509 Phone: 814-868-8266 | |
Phillip Steff, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5042 Peach St, Erie, PA 16509 Phone: 814-616-8028 | |
Elena Akopyan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1535 W 26th St, Erie, PA 16508 Phone: 814-461-1215 | |
Joshua M Botimer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 232 W 54th St, Erie, PA 16544 Phone: 814-452-5000 | |
Dr. Garrett P Jageman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5515 Peach St, Erie, PA 16509 Phone: 814-864-4031 |